Denise Pollard-Knight Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Denise Pollard-Knight.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Denise Pollard-Knight. Denise Pollard-Knight is a Director in IDENIX PHARMACEUTICALS INC ($IDIX) and a Director in OncoMed Pharmaceuticals Inc ($OMED) and a Director in ALBIREO PHARMA, INC. ($BIOD) and a Director in Elanco Animal Health Inc ($ELAN).
Address: C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE 02139 MA
Companies in which Denise Pollard-Knight is an Insider
ALBIREO PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Denise Pollard-Knight: Director
Holdings: 1,165,447 shares
Latest Transaction: Jun 20 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Elanco Animal Health Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Denise Pollard-Knight: Director
Holdings: 8,016 shares
Latest Transaction: Dec 02 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDENIX PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Denise Pollard-Knight: Director
Holdings: 301,476 shares
Latest Transaction: Jun 11 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OncoMed Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Denise Pollard-Knight: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 25 2018
$OMED Market Capitalization: $294.51M
$OMED Previous Close: $8.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Denise Pollard-Knight
Sentiment: All, ALBO, ELAN, IDIX, OMED
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 02 2019 | ELAN | Elanco Animal Heal ... | Scots-Knight Denise | Director | Grant | A | 0.00 | 5,233 | 0 | 8,016 | 2.8 K to 8 K (+188.03 %) |
| Dec 02 2019 | ELAN | Elanco Animal Heal ... | Scots-Knight Denise | Director | Grant | A | 0.00 | 5,233 | 0 | 8,016 | 2.8 K to 8 K (+188.03 %) |
| Apr 12 2019 | ELAN | Elanco Animal Heal ... | Scots-Knight Denise | Director | Grant | A | 0.00 | 2,783 | 0 | 2,783 | 0 to 2.8 K |
| Jun 25 2018 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Option Exercise | A | 2.55 | 15,000 | 38,250 | 15,000 | |
| Jun 20 2017 | ALBO | ALBIREO PHARMA, IN ... | Pollard-Knight Denise | Director | Option Exercise | A | 17.05 | 3,000 | 51,150 | 3,000 | |
| Jun 02 2017 | OMED | OncoMed Pharmaceut ... | Pollard-Knight Denise | Director | Option Exercise | A | 3.30 | 15,000 | 49,500 | 15,000 | |
| Jan 25 2017 | BIOD | ALBIREO PHARMA, IN ... | Pollard-Knight Denise | Director | Option Exercise | A | 18.54 | 4,500 | 83,430 | 4,500 |